Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial
PaperCitations, authors & open-access status
Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 180 citations, 2023 year and green oa status.
180
Citations
2023
Year
green
OA Status